The granulomatous immune response in tuberculosis is characterized by delayed hypersensitivity and is mediated by various cytokines released by the stimulated mononuclear phagocytes, including tumor necrosis factor-a (TNFa) 
chills, and weight loss that frequently exceeds 10 kg over several months ( 1) . These symptoms are typical of the acutephase response and are considered to be mediated by the cytokines tumor necrosis factor-a (TNFa) ' and IL-1f released by mononuclear phagocytes (2) (3) (4) (5) . These cytokines have multiple actions that likely play a role in local granuloma formation and inflammation. It is now well established that mycobacteria and mycobacterial proteins can stimulate the release of IL-1$ and TNFa (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) Chensue and colleagues (9) reported that peripheral blood mononuclear cells from patients with active tuberculosis released increased amounts of IL-11, and Takashima et al. (7) showed peripheral blood monocytes from active tuberculosis patients released increased amounts of TNFa in response to a stimulus compared with controls or patients with chronic refractory tuberculosis. TNFa release has also been shown to be higher in tuberculosis patients with fever rather than no fever (17) and was detected in the serum of Brazilian tuberculosis patients ( 18) . In tuberculous pleuritis, high levels of (IFN'y) and TNFa have been found in pleural fluid, and mRNA for both cytokines was detected in pleural tissue by in situ hybridization (6) . Moreno and colleagues (8) demonstrated that the mycobacterial cell wall product, purified lipoarabinomannan (LAM), stimulated TNFa from peripheral blood monocytes in a dose-response manner. Importantly, they confirmed that the ability of LAM to stimulate TNFa was apart from any contaminating LPS: they copurified LAM and TNFa-inducing activity over an affinity column containing a monoclonal antibody to LAM; purification over SDS-PAGE demonstrated TNFa-releasing activity in the molecular weight range of LAM; and LAM incubated in weak NaOH that inhibits LPS activity still stimulated TNFa (8) . Barnes and colleagues ( 15) confirmed that weak alkali treatment removing acyl groups from the phosphoinositol membrane backbone ofLAM greatly reduced the TNFa-inducing activity of LAM. They demonstrated that LAM and other cell wall products lacking carbohydrate moieties could induce TNFa whereas deacylated LAM could not. Using the polymerase chain reaction, monocytes expressed IL-la, IL-1If, IL-6, IL-8, IL-I 0, TNFa, and granulocyte macrophage colony-stimulating factor after LAM stimulation ( 15 ) . The mycobacterial cytosolic heat shock protein-65 kD (HSP-65kD) has been shown to release TNFa from cytotoxic effector cells ( 14) . Lastly, TNFa has been found to be released by monocytes obtained from leprosy patients, especially those with the tuberculoid form or erythema nodosum leprosum, and Mycobacterium leprae proteins stimulated TNFa release in vitro ( 12, 13) . In a murine model of BCG-in-duced granulomas ( 19) , TNFa synthesis coincided with the development of granulomas. Injection of anti-TNFa antibody blocked accumulation of TNFa mRNA and protein, dramatically reduced the number and size of BCG-induced granulomas, and reduced the accumulation of large epithelioid cells.
We dissected the mechanisms ofthe host immune response to tuberculosis by evaluating the protein release and gene expression of IL-1,B and TNFa in mononuclear phagocyte cells after stimulation with a variety ofrecombinant or purified proteins from M. tuberculosis. We evaluated a cell culture filtrate from M. tuberculosis Erdman strain, the purified M. tuberculosis cell wall component LAM from strains H37Ra and Erdman, live M. tuberculosis H37Ra, and the mycobacterial cytosol recombinant HSP-65kD. All of these mycobacterial products were carefully evaluated to assure that they were devoid of contaminating LPS. An anti-LAM antibody was used to evaluate the specificity of the effect. To determine how these M. tuberculosis proteins stimulated cytokines, we compared them to LPS after using anti-CD 14 monoclonal antibodies and measured TNFa and IL-lIl. Lastly, to determine the mechanism of IL-1f gene regulation, we isolated a 1.4-kb fragment of 5' genomic DNA and evaluated the responsiveness of this fragment after stimulation with the same stimuli. Van der Zee, National Institute of Public Health and Environmental Protection (Bilthoven, Netherlands). The CFL was devoid of LAM and phosphoinositol mannoside after anion-exchange chromatography that removed carbohydrate moieties and molecular sieve chromatography that excluded LAM on the basis of size. The LAM had been eluted through Detoxi-Gel (Pierce Chemical Co., Rockford, IL) using sterile pyrogen-free water and stored in pyrogen-free vials. Only pyrogen-free water was used in reconstitution of this material. Evaluation of tuberculosis reagents for the presence ofGram-negative bacterial endotoxin was done with the amebocyte lysate assay (E-toxate kit; Sigma Chemical Co.).
Methods
The ELISA kit for TNFa assay was from Biokine (Cambridge, MA), and the kit for IL-I1 assay was kindly supplied by Dr antibody. An anti-LAM monoclonal antibody (kindly provided by P. Brennan, Ft. Collins, CO) was added in increasing concentration to THP-I cells cultured in 24-well tissue culture plates at a density of 106 cells/ ml with LAM (500 ng/ml). In addition, we evaluated a dose-response of LPS, LAM, HSP-65kD, or CFL in the presence or absence of anti-LAM (3 gtg/ml) and measured IL-1I3 and TNFa release. The anti-LAM monoclonal antibody ML9D3 from ascites fluid was at a titer of 1: 1,600 and is a member of the 900 series of IgG3 subclass antibodies described by Gaylord et al. (20) .
Isolation of RNA and Northern blot analysis. THP-I cells were treated with test agents for specified time periods, collected by centrifugation, and lysed by addition of 5.5 M guanidinium isothiocyanate buffer. Cytoplasmic RNA was isolated through CsCl2 gradient ultracentrifugation. Equal amounts of the extracted RNA were fractionated by electrophoresis through a 1% agarose-6% formaldehyde denaturing gel, transferred onto a nitrocellulose filter (BA 85; Schleicher & Schuell, Inc., Keene, NH), and baked at 80°C for 2 h. The baked filter was incubated in 40 ml of prehybridization solution (50% formamide, 0.5% SDS, lOX Denhardt's, 2.5% herring sperm DNA, and 4x SSPE) at 42°C for 12 h. An IL-lIO cDNA probe (kindly provided by S. Gillis, Immunex, Seattle, WA), TNFa cDNA probe (Genentech, Inc., South San Francisco, CA), or pHe7 cDNA probe were radiolabeled with a-
[32P]dCTP (sp act 3,000 Ci/mmol; New England Nuclear, Boston, MA) by nick translation. Hybridization was carried out at 42°C for 10 h. The filter was then washed in 2x SSC/0.5% SDS at room temperature for 20 min followed by 0.1X SSC/0.5% SDS at 65°C for 30 min.
Autoradiography was performed at -70°C for 9-48 h.
Nuclear run-on assay. THP-1 cells were stimulated for 1 h, collected by centrifugation, and washed with cold PBS. The cell pellet was incubated in 4 ml NP-40 lysis buffer (10 mM Tris, pH 7.5; 10 mM NaCl; 3 mM MgC12; 0.5% NP-40). The lysate was centrifuged for 500g
for S min at 4°C. The isolated nuclei were then stored in 200 ,l glycerol buffer (50 mM Tris, pH 8.3; 40% glycerol; 5 mM MgC12; 0.1 mM EDTA) after gentle vortexing in liquid nitrogen. The samples were then extracted with phenol and precipitated with TCA. The precipitates were treated with DNase I and the filterbinding RNA was eluted at 65°C for 10 min. The eluted RNA was digested again with proteinase K, denatured in NaOH, and precipitated with ethanol. Equal amounts ofcounts per minute > 3 X 106 cpm) was added to the nitrocellulose filter, on which denatured plasmid DNA was immobilized, in hybridization solution. After hybridization the filters were washed and autoradiography was performed at -70°C for 3 d.
Screening of human genomic library and plasmid construction. A human genomic placental library was purchased from Clontech (Palo Alto, CA). Using a cDNA and synthetic oligonucleotide sequence of IL-1IB as probes, 3 X 1O6 plaques were screened. This resulted in eight positive clones of which one was used for subcloning. An IL-IO DNA fragment from -1 130 to +290 was isolated with restriction enzyme
XbaI and subcloned into a polylinker site on plasmid vector pTK.CAT, which contains the herpes simplex virus thymidine kinase promoter and a chloramphenicol acetyl transferase (CAT) structural gene (kindly provided by Dr. Herbert Samuels, New York University Medical Center). The TK promoter was then removed by digestion with BamHI and BglII to produce the plasmid pTK(-)CAT.IL-l,3. Transient transfection ofhuman suspension cultures and the assay of CAT activity. THP-1 cells were transfected with the plasmid pTK(-)CAT.IL-l3 by the DEAE-dextran method (21) . Briefly, 107 cells were washed in suspension ofTris-buffered saline (STBS) solution with the following composition (mM): 25 Tris, pH 7.4; 137 NaCl; 5 KCl; 0.6 Na2HPO4; 0.7 CaCl2, 0.5 MgCl2, transfected with 10 ,tg cesium chloride-purified plasmids in 1 ml STBS solution at 370C for 90 min, and then shocked with 10% DMSO for 5 min. The transfected cells were then washed with STBS solution and incubated in complete medium for 24 h in the absence or presence of inducing agents. The transfected cells were lysed by three freeze-thawing cycles, and equal amounts of protein from different cell extracts were assayed for CAT activity (22) . The protein concentration was determined with reagents (Bio-Rad Laboratories, Richmond, CA). For the CAT assay, 100 jug protein was incubated with 0.1 ,uCi ['4C]chloramphenicol; 250 mM Tris, pH 7.5; and 360 ,g/ml acetyl coenzyme A in a total volume of 170 ,l at 37°C for 5 h. The reactions were stopped by the addition of 0.5 ml of cold ethyl acetate. After extraction with ethyl acetate, the upper layer was dried and spotted onto a TLC plate. The plate was developed in 95% chloroform/ 5% methanol, air dried, and exposed to x-ray film. Radioactive spots were removed from the plate for scintillation counting.
Results
Evaluation ofM. tuberculosis reagentsfor LPS contamination. The LAM, HSP-65kD, and CFL used in the experiments were first evaluated using the amebocyte lysate assay for LPS contamination. An LPS standard curve was generated and the limit ofthe assay was 1 pg/ml ofLPS. Six batches ofLAM used in these experiments contained < 10 pg LPS/ 1 ,ug LAM. The HSP-65kD, CFL, MY4, and C3 10 anti-CD 14 monoclonal antibody contained 1 pg LPS/ 1 ,ug test reagent. A dose-response experiment demonstrated no release of TNFa from THP-1 cells at LPS concentrations of 10 pg/ml with a detectable release at 100 pg/ml similar to that shown by others (23) .
Release of TNFa and IL-]1 by THP-J cells after stimulation by M. tuberculosis and its components. The human myelomonocytic leukemia cell line THP-1 is known to release cytokines similar to mononuclear phagocytic cells. After 24 h of stimulation with LPS or LAM, the release of TNFa and IL-1O
by LPS was approximately one order ofmagnitude greater than LAM (Fig. 1, A and B) . By contrast, the release of TNFa and IL-13 by HSP-65kD and CFL was almost two orders of magnitude less than LAM. We also confirmed that LAM from the virulent M. tuberculosis Erdman strain was barely able to elicit a cytokine response. In release. The cell surface protein CD 14 binds the complex consisting of LPS and the LPS-binding protein (23) . To determine whether M. tuberculosis components and LPS induce TNFa and IL-1p release by the same or different mechanisms, we compared the blocking ability of anti-CD14 monoclonal antibodies on this activity. Fig. 2 , A-D, shows that anti-CD 14 monoclonal antibody MY4 blocked induction of both TNFa and IL-IO3 by LPS and LAM from human blood over 6 h. The inhibition occurred over the dose range 100 pg/ml to 10 ng/ml for LPS and up to 100 ng/ml for LAM. An isotype IgG2b control monoclonal antibody had no effect (Fig. 2, A-D ulation, although doses required for cytokine release by HSP65kD and CFL were much higher than LAM. We obtained similar results with 3C10, another monoclonal antibody to a different epitope on CD14 (data not shown).
Anti-LAM antibody blocks TNFa and IL-13 release. To determine the specificity of the stimulus by LAM for TNFa or IL-113 release by THP-1 cells, we performed a dose-response evaluation using anti-LAM monoclonal antibody (Fig. 3) . The anti-LAM antibody reduced TNFa or IL-13 release from THP-1 cells after stimulation with LAM in a dose-dependent fashion, confirming the specificity of the response. The anti-LAM monoclonal antibody did not reduce TNFa or IL-11 release from THP-1 cells after stimulation with LPS, HSP-65kD, or CFL (Fig. 4, A and B) .
Expression ofmRNAsfor IL-i13 and TNFa in THP-J cells. After a 5-h exposure with LPS, THP-1 cells expressed the expected 1.6-kb IL-11 and 1.7-kb TNFa mRNA species by Northern blot analysis (Fig. 5) . Interestingly, the LPS-free preparation of the M. tuberculosis cell wall, LAM, demonstrated identical upregulation of IL-113 and TNFa mRNA as LPS (Fig.  5, A and B, lanes 2 and 3) . The recombinant HSP-65kD, a cytoplasmic protein ubiquitous among mycobacterial species, and culturefiltrate CFL shared a similar ability in upregulating IL-13 and TNFa mRNA at 5 h (Fig. 5, A and B, lanes 4 and 8) .
Increased IL-11 mRNA levels were observed within 30 min after stimulation with LPS, LAM, HSP-65kD, and CFL and lasted > 24 h. Equal amounts of mRNA were placed in each lane as demonstrated by the control housekeeping cDNA pHe 7 (Fig. 5 C) . IL-JI, gene transcription and regulation by M. tuberculosis. To determine if the transcription rate of mRNA for IL-1/3 was increased, we used a nuclear run-on assay (Fig. 6) . The IL-/3 cDNA and housekeeping control gene (/3-actin) were fixed to nitrocellulose, and the stimulated cell extracts demonstrated an increased transcription rate after LPS, LAM, or TNFa exposure (Fig. 6, lanes 2, 3, and 4 , respectively, compared with untreated cells, lane 1).
To further investigate the molecular mechanisms by which the expression of the IL-/3 gene is regulated upon exposure to M. tuberculosis and other stimuli, we isolated the IL-1/3 genomic DNA from a human placenta library. A 1,420-bp IL-1/3 DNA fragment (-1130/+290) in pTK(-)CAT.IL-i/ was evaluated by transient transfection and CAT assay after stimulation with TNFa, LPS, LAM, CFL, and HSP-65kD. The same test agents that upregulated steady state IL-1/ mRNA levels (see Fig. 6 ) enhanced CAT gene expression driven by the IL-13f promoter in THP-1 cells (Fig. 7) . By comparison with the unstimulated control, the enhanced IL-1/3 promoter activity was > 14-fold upon stimulation with LAM or HSP-65kD and was sixfold greater with CFL.
Discussion
Tuberculosis is characterized by recruitment of alveolar and interstitial macrophages and lymphocytes with granuloma formation and systemic symptoms of fever, chills, and night sweats. We as well as others have postulated that local mononuclear phagocyte activation occurs and that cytokines are released (6-16). Using in vitro stimulation by M. tuberculosis and its components, we demonstrated increased IL-I / and TNFa protein release, mRNA expression, and showed that activation occurs via the cell surface protein CD14 and that activation for IL-1/ occurs at the level of transcription.
LAM has recently been shown to contain a phosphatidylinositol membrane anchor that is altered by deacylation removing palmitic (hexodecanoate) and tuberculostearic (10-methyloctadecanoic) acids (24) . Barnes and colleagues (15) demonstrated that deacylated LAM was unable to stimulate cytokines, including IL-IlB and TNFa. Chatterjee and colleagues ( 16) explored the structural basis ofthe action ofLAM, observing that LAM from the virulent M. tuberculosis Erdman strain released 100-fold less TNFa from murine macrophages than LAM from the attenuated M. tuberculosis H37Ra strain. They postulated that extensive capping of arabannan moieties by mannan in the Erdman virulent strain allowed it to escape eukaryotic host-defense mechanisms, including TNFa release. Our results with the M. tuberculosis Erdman strain confirm the results of Chatterjee et al. ( 16) for TNFa and extend them to IL-13. LAM has been considered an important virulence factor of M. tuberculosis with ability to downregulate IFN-y activation of macrophages, downregulate IFNy-inducible genes in macrophages, inhibit protein-antigen processing by antigenpresenting cells, scavenge superoxide anion, and decrease protein kinase C activity (25) (26) (27) (28) .
We carefully evaluated all of our samples of LAM, HSP65kD, and CFL for LPS contamination using the Limulus amebocyte lysate assay, consistently observing < 10 pg/I ,Ig test reagent, which was below the level that LPS was able to stimulate cytokine release in THP-1 cells. Using the same as- (29) added polymyxin B or the specific LPS inhibitor diphosphoryl lipid A to LAM test wells and obtained the same result. Addition of anti-LAM monoclonal antibody of the IgG3 900 series abrogated the stimulatory activity of LAM for TNFa or IL-13 with no effect on LPS stimulation, further demonstrating that the effect of LAM was not due to contaminating LPS. In addition, anti-LAM had no effect on HSP-65kD or CFL, suggesting that M. tuberculosis proteins other than LAM have the ability to stimulate cytokines, although less striking than LAM.
In addition to LAM, we evaluated a CFL ofthe M. tuberculosis Erdman strain that was free of carbohydrate moieties and the recombinant HSP-65kD. The CFL was purified over anion-exchange and molecular sieve chromatography and was free of LAM contamination by Western blot. Mycobacterial culture filtrates have proteins (46 and 20 kD) reported to stimulate TNFa release by peripheral blood monocytes ( 11) . We found that both proteins were weaker stimuli than LAM for IL-I# or TNFa release with the only exception being the transcription experiment using -HSP-65kD. HSP-65kD is a cytosolic protein important for intracellular protein assembly, folding, and transport.
We also show that LAM and LPS both stimulate peripheral blood mononuclear cells to release TNFa and IL-13 at low doses ( < 10 ng/ml) by interacting with the CD14 surface protein. The release of TNFa and IL-,l/ stimulated by LAM (38) . Since mononuclear phagocytes are also important in the formation of tubercle granulomas, these cytokines may also mediate phagocyte differentiation into epithelioid cells, the release ofextracellular matrix, the cellular organization typical of granulomas, and the central caseation necrosis. Further studies of alveolar macrophages and tissue biopsies from patients with active tuberculosis will provide data on the role of IL-13 and TNFa in vivo.
